Peter J. Rossi

MedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial”.

18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial

The Lancet(2021)10.1016/s0140-6736(21)00581-x

N/A

6.4DataRank · unranked

186 citations

Eduard Schreibmann, Subir Goyal, Raghuveer Halkar, Bruce Hershatter, Peter J. Rossi +14 more

The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assurance

Brachytherapy(2020)10.1016/j.brachy.2020.10.001

N/A

0.434DataRank · unranked

17 citations

Firas Mourtada, Juanita Crook, Peter F. Orio, Richard G. Stock, Daniel G. Petereit +9 more

Randomized Trial of Conventional Versus Conventional Plus Fluciclovine (18F) Positron Emission Tomography/Computed Tomography–Guided Postprostatectomy Radiation Therapy for Prostate Cancer: Volumetric and Patient-Reported Analyses of Toxic Effects

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2022.04.005

N/A

0.391DataRank · unranked

4 citations

David M. Schuster, Subir Goyal, Eduard Schreibmann, Bruce Hershatter, Peter J. Rossi +4 more

Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancer

Brachytherapy(2021)10.1016/j.brachy.2021.07.005

N/A

0.345DataRank · unranked

9 citations

Benjamin W. Fischer‐Valuck, Subir Goyal, Yuan Liu, Tiffany Morgan, Elizabeth Ghavidel +8 more

Association of Brachytherapy Boost with Overall Survival for Gleason 9-10 Prostate Cancer: The Impact of Primary versus Secondary Pattern 5

Brachytherapy(2023)10.1016/j.brachy.2022.12.004

N/A

0.241DataRank · unranked

4 citations

Brian C. Baumann, Jeff M. Michalski, Randall Brenneman, Bill Zheng, Hiram A. Gay +6 more